MORGAN NEIDRICK: Open Payments
NPI 1871065656 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,652 in 132 payments from 23 companies in 2025. Trend: 2023 $1,501 · 2024 $1,924 · 2025 $2,652
Food & beverage: $2,652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $557 |
| Ardelyx, Inc. | 16 | $331 |
| PFIZER INC. | 13 | $223 |
| Regeneron Healthcare Solutions, Inc. | 8 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $187 |
| Janssen Biotech, Inc. | 11 | $184 |
| Madrigal Pharmaceuticals | 5 | $181 |
| Phathom Pharmaceuticals, Inc. | 7 | $136 |
| Organon LLC | 4 | $79 |
| Ipsen Biopharmaceuticals, Inc | 3 | $75 |
Products named: IBSRELA, DUPIXENT, RINVOQ, TREMFYA, CREON, REZDIFFRA, VOQUEZNA, XELJANZ.
Industry payments across PA — which companies pay providers there.
